These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 38906511

  • 1. Serum deprivation protein response intervenes in the proliferation, motility, and extracellular matrix production in keloid fibroblasts by blocking the amplification of TGF-β1/SMAD signal cascade via ERK1/2.
    Li P, Han M, Wang L, Gao C.
    Toxicol Appl Pharmacol; 2024 Aug; 489():117012. PubMed ID: 38906511
    [Abstract] [Full Text] [Related]

  • 2. Silencing NLRC5 inhibits extracellular matrix expression in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway.
    Ma HL, Zhao XF, Chen GZ, Fang RH, Zhang FR.
    Biomed Pharmacother; 2016 Oct; 83():1016-1021. PubMed ID: 27525969
    [Abstract] [Full Text] [Related]

  • 3. Knockdown of FOXM1 inhibits activation of keloid fibroblasts and extracellular matrix production via inhibition of TGF-β1/Smad pathway.
    Zhang Y, Cheng C, Wang S, Xu M, Zhang D, Zeng W.
    Life Sci; 2019 Sep 01; 232():116637. PubMed ID: 31288014
    [Abstract] [Full Text] [Related]

  • 4. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach.
    Wu CS, Wu PH, Fang AH, Lan CC.
    Br J Dermatol; 2012 Sep 01; 167(3):532-41. PubMed ID: 22540338
    [Abstract] [Full Text] [Related]

  • 5. Knockdown of IRF3 inhibits extracellular matrix expression in keloid fibroblasts.
    Zhang Y, Zhang L, Lin XH, Li ZM, Zhang QY.
    Biomed Pharmacother; 2017 Apr 01; 88():1064-1068. PubMed ID: 28192879
    [Abstract] [Full Text] [Related]

  • 6. Downregulation of CR6-interacting factor 1 suppresses keloid fibroblast growth via the TGF-β/Smad signaling pathway.
    Nagar H, Kim S, Lee I, Kim S, Choi SJ, Piao S, Jeon BH, Oh SH, Kim CS.
    Sci Rep; 2021 Jan 12; 11(1):500. PubMed ID: 33436666
    [Abstract] [Full Text] [Related]

  • 7. TMEM88 inhibits extracellular matrix expression in keloid fibroblasts.
    Zhao H, Lu F, Cui S, Zhang X, Wang W, Si E, Yuan Z.
    Biomed Pharmacother; 2017 Nov 12; 95():1436-1440. PubMed ID: 28946191
    [Abstract] [Full Text] [Related]

  • 8. Increased Cthrc1 Activates Normal Fibroblasts and Suppresses Keloid Fibroblasts by Inhibiting TGF-β/Smad Signal Pathway and Modulating YAP Subcellular Location.
    Zhao MJ, Chen SY, Qu XY, Abdul-Fattah B, Lai T, Xie M, Wu SD, Zhou YW, Huang CZ.
    Curr Med Sci; 2018 Oct 12; 38(5):894-902. PubMed ID: 30341526
    [Abstract] [Full Text] [Related]

  • 9. Sorafenib exerts an anti-keloid activity by antagonizing TGF-β/Smad and MAPK/ERK signaling pathways.
    Wang W, Qu M, Xu L, Wu X, Gao Z, Gu T, Zhang W, Ding X, Liu W, Chen YL.
    J Mol Med (Berl); 2016 Oct 12; 94(10):1181-1194. PubMed ID: 27339758
    [Abstract] [Full Text] [Related]

  • 10. Suppression of TGF-β1/SMAD pathway and extracellular matrix production in primary keloid fibroblasts by curcuminoids: its potential therapeutic use in the chemoprevention of keloid.
    Hsu YC, Chen MJ, Yu YM, Ko SY, Chang CC.
    Arch Dermatol Res; 2010 Dec 12; 302(10):717-24. PubMed ID: 20717830
    [Abstract] [Full Text] [Related]

  • 11. ADAM17 regulates the proliferation and extracellular matrix of keloid fibroblasts by mediating the EGFR/ERK signaling pathway.
    Le X, Fan YF.
    J Plast Surg Hand Surg; 2023 Dec 12; 57(1-6):129-136. PubMed ID: 34978504
    [Abstract] [Full Text] [Related]

  • 12. Keloid Core Factor CTRP3 Overexpression Significantly Controlled TGF-β1-Induced Propagation and Migration in Keloid Fibroblasts.
    He L, Zhu C, Dou H, Yu X, Jia J, Shu M.
    Dis Markers; 2023 Dec 12; 2023():9638322. PubMed ID: 37091895
    [Abstract] [Full Text] [Related]

  • 13. Oleanolic acid regulates the proliferation and extracellular matrix of keloid fibroblasts by mediating the TGF-β1/SMAD signaling pathway.
    Luo Y, Wang D, Yuan X, Jin Z, Pi L.
    J Cosmet Dermatol; 2023 Jul 12; 22(7):2083-2089. PubMed ID: 36847714
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. TRAF3IP2 regulated by FOXO4 affects fibroblast proliferation, migration, and extracellular matrix deposition in keloid through the TGF-β1/Smad pathway.
    Yan Q, Li B.
    J Cosmet Dermatol; 2022 Oct 12; 21(10):5148-5155. PubMed ID: 35441794
    [Abstract] [Full Text] [Related]

  • 17. Syndecan-1 regulates extracellular matrix expression in keloid fibroblasts via TGF-β1/Smad and MAPK signaling pathways.
    Cui J, Jin S, Jin C, Jin Z.
    Life Sci; 2020 Aug 01; 254():117326. PubMed ID: 31954164
    [Abstract] [Full Text] [Related]

  • 18. DKK3 regulates cell proliferation, apoptosis and collagen synthesis in keloid fibroblasts via TGF-β1/Smad signaling pathway.
    Li Y, Liu H, Liang Y, Peng P, Ma X, Zhang X.
    Biomed Pharmacother; 2017 Jul 01; 91():174-180. PubMed ID: 28458155
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Halofuginone regulates keloid fibroblast fibrotic response to TGF-β induction.
    Marty P, Chatelain B, Lihoreau T, Tissot M, Dirand Z, Humbert P, Senez C, Secomandi E, Isidoro C, Rolin G.
    Biomed Pharmacother; 2021 Mar 01; 135():111182. PubMed ID: 33433355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.